Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer EDITORIAL COMMENT

dc.contributor.authorBurger, Robert A.en_US
dc.contributor.authorBrady, Mark F.en_US
dc.contributor.authorBookman, Michael A.en_US
dc.contributor.authorFleming, Gini F.en_US
dc.contributor.authorMonk, Bradley J.en_US
dc.contributor.authorHuang, Helenen_US
dc.contributor.authorMannel, Robert S.en_US
dc.contributor.authorHomesley, Howard D.en_US
dc.contributor.authorFowler, Jeffreyen_US
dc.contributor.authorGreer, Benjamin E.en_US
dc.contributor.authorBoente, Matthewen_US
dc.contributor.authorBirrer, Michael J.en_US
dc.contributor.authorLiang, Sharon X.en_US
dc.contributor.cuauthorMonk, Bradley J.en_US
dc.date.accessioned2014-06-27T13:48:49Z
dc.date.available2014-06-27T13:48:49Z
dc.date.issued2012en_US
dc.date.year2012en_US
dc.description.issue5en_US
dc.description.pages289-290en_US
dc.description.volume67en_US
dc.identifier.citationBurger, Robert A.; Brady, Mark F.; Bookman, Michael A.; Fleming, Gini F.; Monk, Bradley J.; Huang, Helen; Mannel, Robert S.; Homesley, Howard D.; Fowler, Jeffrey; Greer, Benjamin E.; Boente, Matthew; Birrer, Michael J.; Liang, Sharon X. Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer EDITORIAL COMMENT. Obstetrical & gynecological survey. 2012, 67(5):289-290.en_US
dc.identifier.issn0029-7828en_US
dc.identifier.issn1533-9866en_US
dc.identifier.urihttp://hdl.handle.net/10504/61080
dc.program.unitSchool of Medicineen_US
dc.program.unitObstetrics and Gynecologyen_US
dc.titleIncorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer EDITORIAL COMMENTen_US
dc.title.workObstetrical & Gynecological Surveyen_US
dc.typeJournal Articleen_US
dc.url.link1http://cuhsl.creighton.edu/login?url=http://kc7za5wx4c.search.serialssolutions.com/?sid=Refworks%3A&charset=utf-8&__char_set=utf8&genre=article&aulast=Burger&auinit=R.A.&title=Obstetrical%20%26%20gynecological%20survey&stitle=Obstet.Gynecol.Surv.&date=2012&volume=67&pages=289-290&issue=5&issn=0029-7828&atitle=Incorporation%20of%20Bevacizumab%20in%20the%20Primary%20Treatment%20of%20Ovarian%20Cancer%20EDITORIAL%20COMMENT&spage=289&au=Burger%2CRobert%20A.&au=Brady%2CMark%20F.&au=Bookman%2CMichael%20A.&au=Fleming%2CGini%20F.&au=Monk%2CBradley%20J.&au=Huang%2CHelen&au=Mannel%2CRobert%20S.&au=Homesley%2CHoward%20D.&au=Fowler%2CJeffrey&au=Greer%2CBenjamin%20E.&au=Boente%2CMatthew&au=Birrer%2CMichael%20J.&au=Liang%2CSharon%20X.&en_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: